By Colin Kellaher
Tyra Biosciences Inc. said its increased IPO of 10.8 million shares at $ 16 apiece was at the top of the expected range of $ 14-16.
The precision oncology company of Carlsbad, California, which had already increased its offering from 6.7 million to 9 million shares, expected gross proceeds of $ 172.8 million.
Tyra said it has also given the syndicate banks a 30-day option to purchase up to an additional 1.62 million shares.
Tyra stock is scheduled to trade under the symbol TYRA on Wednesday.
Write to Colin Kellaher at [email protected]